First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer GroupMarinde J. G. Bond, Johanneke H.M.J.V. Vestjens, Marta López‐Yurda et al.|The Lancet Oncology|2023Cited by 168
First-Line Systemic Treatment for Initially Unresectable Colorectal Liver MetastasesMarinde J. G. Bond, Leonie J. Mekenkamp, Koert P. de Jong et al.|JAMA Oncology|2024Cited by 26
423P From clinical trial to bedside: Triplet chemotherapy (FOLFOXIRI-B) in metastatic colorectal cancerGuus M. Bol, Miriam Koopman, Jesper van Breeschoten et al.|Annals of Oncology|2021Cited by 0